What is the Global market size of the Spinal Cord Stimulation Market?

Global Spinal Cord Stimulation Market size was valued at USD 3.02 billion in 2021 and is poised to grow from USD 3.25 billion in 2022 to USD 5.83 billion by 2030, growing at a CAGR of 7.58% in the forecast period (2023-2030).

Spinal Cord Stimulation Market Size, Share, Growth Analysis, By Indication (Failed Back Surgery Syndrome, Complex Regional Pain Syndrome), By Product (Rechargeable Devices, Non-Rechargeable Devices), By End User (Hospitals), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2711 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 65 | Figures: 74

Spinal Cord Stimulation Market Regional Insights

North America is dominating the global market owing to market expansion as a result of new government regulations and favourable health reimbursement. The market in North America is being driven by the strategic presence of major competitors in the U.S. and new product launches.

Asia Pacific accounted for a significant CAGR during the forecast period. Owing to the presence of a high geriatric population and the quick adoption of neuromodulation therapy, the market growth in manifolds in the coming years. Middle East and Africa, Latin America, and other regions make up the remainder of the world, which has enormous growth potential and is expected to become a valuable market. The expansion of the market in other parts of the world is influenced by factors such as the rising prevalence of chronic back pain and the rising demand for minimally invasive therapies.

Spinal Cord Stimulation Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Spinal Cord Stimulation Market size was valued at USD 2.9 billion in 2022 and is poised to grow from USD 3.13 billion in 2023 to USD 5.7 billion by 2031, growing at a CAGR of 7.8% during the forecast period (2024-2031).

Due to the company's strong emphasis on research and development (R&D) as well as significant acquisitions that will help it in creating cutting-edge devices to manage chronic pain, Medtronic dominated the market by having accounting for a huge revenue share. Healthcare professionals prefer Medtronic spinal cord stimulators because they are easy to use, have long battery lives, produce superior clinical results, and come with outstanding customer support. 'Medtronic plc (Ireland) ', 'Boston Scientific Corporation (USA) ', 'Abbott Laboratories (USA) ', 'Nevro Corp. (USA) ', 'Stimwave Technologies, Inc. (USA) ', 'Saluda Medical Pty Ltd. (Australia) ', 'Synapse Biomedical Inc. (USA) ', 'Cirtec Medical (USA) ', 'Nalu Medical, Inc. (USA) ', 'Beijing PINS Medical Co., Ltd. (China) ', 'Gimer Medical (China) ', 'BIOTRONIK SE & Co. KG (Germany) ', 'St. Jude Medical, Inc. (acquired by Abbott) (USA) ', 'NeuroSigma, Inc. (USA) ', 'Greatbatch, Inc. (USA) ', 'Curonix LLC (USA) ', 'Teliatry, Inc. (USA) ', 'Spinal Modulation (USA) ', 'NevroSpin (USA) ', 'Axonics Modulation Technologies, Inc. (USA)'

The makers have intensified their research efforts in an effort to make spinal cord stimulators smaller. For instance, the Stimwave LCC-produced Freedom SCS system is roughly 5% smaller than the existing Implantable Pulse Generators (IPG) on the market. The rise of the spinal cord stimulation market is being driven by this as well as improvements in impulse production.

Government Initiatives to Reduce Opioid Dependence: The governments of the U.S., Europe, and other countries have stepped up their efforts to lessen opioid dependence. Due to this, alternative therapies that do not need opioids are gradually becoming more popular, and demand for spinal cord stimulation devices is increasing. For instance, firms requesting a quick approval procedure for devices that can be used in place of opioids for pain management submitted more than 200 submissions to the FDA. In order to take advantage of this potential, medical device companies like Medtronic, Abbott, and Boston Scientific are constantly conducting research

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Spinal Cord Stimulation Market Size, Share, Growth Analysis, By Indication (Failed Back Surgery Syndrome, Complex Regional Pain Syndrome), By Product (Rechargeable Devices, Non-Rechargeable Devices), By End User (Hospitals), By Region - Industry Forecast 2024-2031

Spinal Cord Stimulation Market Regional Insights

Spinal Cord Stimulation Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Spinal Cord Stimulation Market?

Who are the key vendors in the Spinal Cord Stimulation Market?

What is the key driver of Spinal Cord Stimulation Market?

What is the key market trend for Spinal Cord Stimulation Market?

Which region accounted for the largest share in Spinal Cord Stimulation Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300